Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
Dong Ji, Jing Xu, Enqiang Qin, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau
Topics & Concepts
Fatty liverDiseaseMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Liver diseaseInternal medicineGastroenterologyInfectious disease (medical specialty)Liver Disease Diagnosis and TreatmentPancreatitis Pathology and TreatmentCOVID-19 Clinical Research Studies